05/10/2024
9:37 AM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:29 PM | Kiromic BioPharma (Issuer)
Mirandola Leonardo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
4:00 PM | BERSANI PIETRO (Filed by)
Kiromic BioPharma (Subject)
| Form SC 13D/A | |
05/07/2024
5:17 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:30 PM | Kiromic BioPharma (Filer)
| Form PRE 14A | |
05/07/2024
4:00 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/19/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form RW | |
04/05/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:21 PM | Kiromic BioPharma (Filer)
| Form 10-K/A | |
03/20/2024
4:58 PM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:55 PM | Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:57 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:56 PM | Kiromic BioPharma (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
01/11/2024
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
9:25 AM | Empery Asset Management, LP (Filed by)
Kiromic BioPharma (Subject)
| Form SC 13G/A | |
11/20/2023
7:46 AM | Kiromic BioPharma (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
11/09/2023
8:49 AM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:05 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:06 PM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:07 PM | Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:07 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:08 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:05 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
3:45 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
3:52 PM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
11:28 AM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:31 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
2:53 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:21 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:22 PM | Kiromic BioPharma (Filer)
| Form DEFA14A | |
06/29/2023
3:33 PM | Kiromic BioPharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/27/2023
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:23 PM | Kiromic BioPharma (Filer)
| Form DEF 14A | |
06/12/2023
3:22 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
3:16 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
“Dollar Will Be Worth NOTHING” -Musk (Ad) Elon Musk just issued an urgent warning…
Saying “The U.S. Dollar will be worth NOTHING…”
As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher. Click here to claim your free seat ticket now. |
05/22/2023
9:31 AM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2023
11:15 PM | Kiromic BioPharma (Filer)
| Form EFFECT | |
05/19/2023
3:49 PM | Kiromic BioPharma (Filer)
| Form 424B3 | |
